Erythrocyte membrane-camouflaged polymeric nanoparticles as a biomimetic delivery platform

Summary

This study demonstrates a top-down method for extending nanoparticle circulation by coating biodegradable polymer cores with complete red-blood-cell membrane, including native lipids and associated proteins. Transmission electron microscopy, dynamic light scattering, and gel electrophoresis were used to verify structure, size, surface charge, and membrane-protein content. After injection into mice, fluorescently labeled membrane-coated particles circulated longer than control particles carrying then-standard synthetic stealth coatings. Biodistribution measurements showed substantial material remaining in blood 72 hours after administration. The principal result is that natural membrane components and their functions can be transferred to a synthetic carrier sufficiently well to alter systemic persistence. This is significant because it replaces reductionist surface modification with an integrated cellular interface while retaining an engineerable core for cargo delivery. However, the abstract does not provide numerical half-lives, blood concentrations, animal numbers, organ accumulation, cargo release, efficacy, immune assays, or toxicity. Fluorescent signal may not fully distinguish intact particles from released label, and persistence alone does not establish therapeutic benefit. Donor variability, membrane orientation, pathogen safety, storage, repeat administration, scale-up, quality control, and performance in humans remain unresolved.